MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockade

Cell Death & Disease, Published online: 08 March 2024; doi:10.1038/s41419-024-06524-wMCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockade

Source: Cell death and disease - March 8, 2024 Category: Internal Medicine Authors: Nabanita Mukherjee Elizabeth Katsnelson Tonya M. Brunetti Kylie Michel Kasey L. Couts Karoline A. Lambert William A. Robinson Martin D. McCarter David A. Norris Richard P. Tobin Yiqun G. Shellman Source Type: research